Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market
Holding TSE:KNE?
Track your performance easily

Kane Biotech (KNE) Cash flow

0 Followers

Kane Biotech Cash Flow

TSE:KNE's free cash flow for Q2 2024 was C$-2.20M. For the 2024 fiscal year, TSE:KNE's free cash flow was decreased by C$999.14K and operating cash flow was C$-2.17M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
C$ -4.66MC$ -2.08MC$ -3.04MC$ -2.29MC$ -3.94MC$ -885.37K
Investing Cash Flow
C$ 8.99MC$ -116.14KC$ -107.55KC$ -373.55KC$ -166.11KC$ -167.38K
Financing Cash Flow
C$ -4.94MC$ 2.51MC$ 2.61MC$ 2.81MC$ 4.28MC$ 1.81M
Cash Flow From Discontinued Operation
C$ 469.80KC$ 469.80KC$ 497.33K---
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 2.65MC$ 1.32MC$ 607.57KC$ 1.15MC$ 1.01MC$ 834.13K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
C$ 415.84KC$ 415.84KC$ 973.70K-C$ 695.47KC$ 1.60M
Issuance Of Debt
C$ -4.82MC$ 2.35MC$ 2.25MC$ 1.26MC$ 2.37MC$ -243.26K
Repayment Of Debt
C$ -5.65MC$ 1.52MC$ 1.57MC$ -535.85KC$ -21.27KC$ -500.46K
Free Cash Flow
C$ -4.68MC$ -2.13MC$ -3.13MC$ -2.29MC$ -3.94MC$ -885.37K
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Kane Biotech Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis